GO:0051610 serotonin uptake: Neurotransmitter Clearance Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051610 serotonin uptake describes the directed movement of serotonin (5-hydroxytryptamine, 5-HT) into a cell, typically presynaptic neurons or glial cells.
• Serotonin uptake is the primary mechanism for terminating serotonergic neurotransmission and is mediated by the serotonin transporter (SERT/SLC6A4) and other transport systems.
• Inhibitors of serotonin uptake, including fluoxetine and escitalopram, increase extracellular serotonin concentrations and are used therapeutically in depression.
• Multiple transport mechanisms contribute to serotonin uptake in the intestine, including SERT and organic cation transporters.
• Serotonin uptake can be modulated by receptor signaling, such as kappa opioid receptors, which reduce uptake and escitalopram efficacy in the substantia nigra pars reticulata.
• Environmental and pharmacological factors, including hypoxia and licorice constituents, can alter peripheral serotonin uptake and degradation.
Description
Serotonin (5-hydroxytryptamine, 5-HT) is a monoamine neurotransmitter that modulates mood, appetite, sleep, and gastrointestinal function. The process by which serotonin is moved from the extracellular space into cells, particularly presynaptic neurons and glial cells, is defined by the Gene Ontology term GO:0051610, serotonin uptake. This process is essential for terminating serotonergic signaling and maintaining appropriate neurotransmitter levels in the synaptic cleft. The serotonin transporter (SERT, encoded by SLC6A4) is the principal protein responsible for serotonin uptake, and its activity is the target of widely prescribed antidepressants such as fluoxetine and escitalopram. Serotonin uptake is not limited to the central nervous system; peripheral tissues, including the intestine, also express transport systems that mediate serotonin uptake. Understanding the molecular mechanisms, regulation, and physiological consequences of serotonin uptake is critical for researchers studying neuropsychiatric disorders, gastrointestinal function, and drug action.
serotonin uptake At A Glance
| GO ID | GO:0051610 |
|---|---|
| GO term | serotonin uptake |
| Ontology | biological_process |
| Synonym | 5-HT uptake, 5HT uptake, 5-hydroxytryptamine uptake, serotonin import |
| Major function | Directed movement of serotonin into a cell, typically presynaptic neurons or glial cells |
| Related transporter | SERT (SLC6A4), organic cation transporters, plasma membrane monoamine transporter |
| Physiological role | Termination of serotonergic neurotransmission and regulation of extracellular serotonin levels |
| Pharmacological relevance | Target of selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine and escitalopram |
What Is GO:0051610?
GO:0051610 serotonin uptake is defined as the directed movement of serotonin into a cell, typically presynaptic neurons or glial cells. Serotonin is a monoamine neurotransmitter occurring in the peripheral and central nervous systems. This process includes the import of serotonin across the plasma membrane and is synonymous with 5-HT uptake, 5HT uptake, 5-hydroxytryptamine uptake, and serotonin import.
Why Is serotonin uptake Important in Cell Biology?
Serotonin uptake is a fundamental process in neurobiology and pharmacology because it controls the duration and intensity of serotonin signaling. Dysregulation of serotonin uptake has been implicated in mood disorders, and inhibitors of this process are first-line treatments for depression. Beyond the brain, serotonin uptake in the intestine influences gut motility and nutrient handling. The process is also modulated by receptor signaling and environmental factors, making it a dynamic and context-dependent target for research.
• Terminates serotonergic neurotransmission by clearing serotonin from the synaptic cleft.
• Target of antidepressant drugs known as selective serotonin reuptake inhibitors (SSRIs).
• Regulates extracellular serotonin concentrations, as measured by brain microdialysis.
• Involved in peripheral serotonin homeostasis, including intestinal uptake.
• Modulated by kappa opioid receptor signaling, affecting drug efficacy.
• Influenced by natural compounds such as licorice constituents.
• Affected by environmental stressors like mild hypoxia.
• Relevant to gastrointestinal physiology and potential gut-brain axis research.
• Provides a model for studying transporter kinetics and regulation.
• Implicated in the mechanism of action of antidepressants and mood stabilizers.
What Happens During serotonin uptake?
Recognition and binding of serotonin at the plasma membrane
In simple terms: Serotonin binds to a transporter protein on the outside of the cell.
Serotonin uptake begins when serotonin molecules in the extracellular space are recognized by specific transporter proteins embedded in the plasma membrane. The serotonin transporter (SERT, SLC6A4) is the primary mediator of this step in presynaptic neurons. Other transporters, such as organic cation transporters, can also contribute to serotonin recognition in certain tissues. Binding is dependent on sodium and chloride gradients, which provide the driving force for transport.
Translocation of serotonin across the membrane
In simple terms: The transporter moves serotonin from outside to inside the cell.
Upon binding, the transporter undergoes conformational changes that translocate serotonin across the lipid bilayer into the cytoplasm. This process is energy-dependent and coupled to ion gradients. The activity of SERT is the rate-limiting step for serotonin clearance in many brain regions. Inhibitors such as fluoxetine block this translocation, leading to increased extracellular serotonin.
Intracellular sequestration and metabolism
In simple terms: Once inside, serotonin is either stored or broken down.
After entering the cell, serotonin can be packaged into synaptic vesicles for reuse or degraded by monoamine oxidase (MAO). In peripheral tissues, such as the intestine, serotonin uptake is followed by degradation, and this process can be influenced by environmental factors like hypoxia. The balance between reuptake and degradation determines the overall availability of serotonin.
Regulation of uptake by receptor signaling
In simple terms: Other receptors can change how fast serotonin is taken up.
Serotonin uptake is not a static process; it can be modulated by G-protein coupled receptors. For example, activation of kappa opioid receptors reduces serotonin uptake and diminishes the efficacy of escitalopram in the mouse substantia nigra pars reticulata. This regulation highlights the interplay between different neurotransmitter systems in controlling serotonin levels.
Pharmacological inhibition of serotonin uptake
In simple terms: Drugs can block the transporter and keep serotonin outside the cell longer.
Selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine and escitalopram bind to SERT and inhibit serotonin uptake, thereby increasing extracellular serotonin concentrations. This mechanism underlies their therapeutic effects in depression. Natural compounds, such as licorice constituents, have also been shown to inhibit serotonin re-uptake.
Key Genes Involved in GO:0051610 serotonin uptake
The following genes and proteins are central to serotonin uptake, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC6A4 | Encodes the serotonin transporter (SERT), primary mediator of serotonin uptake | Target of SSRIs; studied in depression and anxiety |
| SLC6A2 | Encodes norepinephrine transporter, can transport serotonin with lower affinity | Contributes to serotonin clearance in some tissues |
| SLC6A3 | Encodes dopamine transporter, can transport serotonin in certain contexts | Potential compensatory uptake mechanism |
| SLC22A1 | Organic cation transporter 1, mediates serotonin uptake in peripheral tissues | Intestinal serotonin uptake |
| SLC22A2 | Organic cation transporter 2, contributes to serotonin transport | Peripheral serotonin homeostasis |
| SLC22A3 | Organic cation transporter 3, involved in serotonin uptake | Intestinal and renal serotonin handling |
| SLC29A4 | Plasma membrane monoamine transporter, transports serotonin | Alternative uptake route in brain and periphery |
| MAOA | Monoamine oxidase A, degrades serotonin after uptake | Regulates intracellular serotonin levels |
| MAOB | Monoamine oxidase B, degrades serotonin | Peripheral serotonin metabolism |
| TPH1 | Tryptophan hydroxylase 1, rate-limiting enzyme for peripheral serotonin synthesis | Provides substrate for uptake |
| TPH2 | Tryptophan hydroxylase 2, rate-limiting enzyme for neuronal serotonin synthesis | Neuronal serotonin supply |
| HTR1A | Serotonin receptor 1A, modulates serotonergic signaling | Feedback regulation of uptake |
| HTR2A | Serotonin receptor 2A, involved in signaling | Indirect modulation of uptake |
| OPRK1 | Kappa opioid receptor, reduces serotonin uptake | Modulates escitalopram efficacy |
| SLC18A2 | Vesicular monoamine transporter 2, packages serotonin into vesicles | Intracellular storage after uptake |
| GNAI1 | G protein subunit alpha i1, downstream of receptors that regulate uptake | Signaling cascade affecting SERT activity |
| PRKCA | Protein kinase C alpha, can regulate transporter trafficking | Post-translational regulation of SERT |
How Is serotonin uptake Regulated?
Serotonin uptake is regulated at multiple levels. Acute regulation involves receptor-mediated signaling; for instance, kappa opioid receptor activation reduces serotonin uptake in the substantia nigra pars reticulata. Chronic regulation includes changes in transporter expression and trafficking. Environmental factors such as mild hypoxia can impact peripheral serotonin uptake and degradation. Pharmacological agents, including SSRIs, directly inhibit the transporter. Additionally, natural compounds like licorice constituents can modulate re-uptake.
serotonin uptake and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC6A4 | Depression, anxiety | Knockout mouse, point mutation knock-in |
| OPRK1 | Modulation of antidepressant efficacy | Conditional knockout, overexpression |
| MAOA | Aggression, mood disorders | Knockout mouse, point mutation |
| TPH2 | Serotonin synthesis deficiency | Knock-in of human variants |
| SLC22A1 | Gastrointestinal serotonin uptake | Intestinal organoids, knockout |
Depression and mood disorders
Alterations in serotonin uptake are strongly implicated in depression. Therapeutic effects of serotonin uptake inhibitors in depression have been demonstrated in clinical studies. Drugs such as fluoxetine, a selective inhibitor of serotonin uptake, are widely prescribed for major depressive disorder. The mechanism involves increasing extracellular serotonin concentrations, as shown by brain microdialysis.
Gastrointestinal disorders
Serotonin uptake in the intestine is critical for gut function. Multiple transport mechanisms contribute to intestinal serotonin uptake, and dysregulation can lead to gastrointestinal disorders. Peripheral serotonin is involved in motility and secretion, and its uptake is a potential therapeutic target.
Substance use and neurological conditions
Kappa opioid receptor signaling reduces serotonin uptake and escitalopram efficacy in the substantia nigra pars reticulata, linking serotonin uptake to reward and motor circuits. This interaction may be relevant to substance use disorders and movement disorders.
From serotonin uptake-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC6A4 knockout alter extracellular serotonin levels? | SLC6A4 knockout mouse, microdialysis |
| How does a point mutation in SERT affect inhibitor binding? | Point mutation knock-in cell lines or mice |
| Can overexpression of SERT increase serotonin uptake? | SERT overexpression in cell culture or transgenic mice |
| What is the role of kappa opioid receptors in serotonin uptake? | OPRK1 knockout or overexpression models |
| How does hypoxia affect peripheral serotonin uptake? | Hypoxia exposure in fish models or cell culture |
| Do licorice constituents inhibit serotonin re-uptake? | In vitro uptake assays with licorice compounds |
How to Study the serotonin uptake Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled uptake assay | Transport activity | Screening inhibitors |
| Microdialysis | Extracellular serotonin levels | In vivo drug effects |
| Knockout mouse models | Physiological role of transporters | Gene function studies |
| Immunohistochemistry | Transporter localization | Tissue distribution |
| Electrophysiology | Transporter currents | Mechanistic studies |
| Pharmacological inhibition | Drug efficacy | Antidepressant development |
| Hypoxia exposure | Environmental modulation | Peripheral uptake studies |
Measuring serotonin uptake in vitro
Radiolabeled serotonin uptake assays are used to quantify transport activity in cell lines or synaptosomes. These assays can test the effects of inhibitors such as fluoxetine or natural compounds.
In vivo microdialysis
Brain microdialysis allows measurement of extracellular serotonin concentrations in living animals, providing direct evidence of uptake inhibition.
Genetic models and knockout studies
Knockout mice for SLC6A4 or other transporters are used to study the physiological consequences of altered serotonin uptake. Conditional knockouts can dissect tissue-specific roles.
Pharmacological profiling
Selective serotonin reuptake inhibitors are used to probe transporter function and to validate targets. Escitalopram efficacy can be assessed in models with altered receptor signaling.
How CRISPR Can Be Used to Study GO:0051610 serotonin uptake
Knockout
CRISPR knockout of SLC6A4 or other serotonin transporters can create cell models to study the loss of uptake function. These models are useful for validating drug targets and understanding compensatory mechanisms.
Point Mutation
Point mutations in SLC6A4 can mimic human polymorphisms that affect transporter activity or inhibitor sensitivity. Such models help dissect the molecular basis of drug response.
Knock-in
Knock-in of tagged SERT (e.g., GFP or HA) allows visualization and tracking of the transporter in live cells, facilitating studies of trafficking and localization.
Overexpression
Overexpression of SERT or other transporters can increase serotonin uptake capacity, providing a system to study the effects of enhanced clearance on signaling and behavior.
How EDITGENE Supports serotonin uptake Research
Researchers studying serotonin uptake-related genes often need to determine whether a candidate gene is causally involved in transporter regulation, drug response, or disease. EDITGENE provides comprehensive CRISPR services to create precisely engineered cell and animal models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for serotonin uptake research.
Frequently Asked Questions About serotonin uptake
What is serotonin uptake?
Serotonin uptake is the directed movement of serotonin into a cell, typically presynaptic neurons or glial cells, as defined by GO:0051610.
What genes are involved in serotonin uptake?
The primary gene is SLC6A4, which encodes the serotonin transporter (SERT). Other genes include SLC22A1, SLC22A2, SLC22A3, and SLC29A4.
How is serotonin uptake measured?
It is measured using radiolabeled uptake assays, microdialysis, or imaging techniques.
What drugs inhibit serotonin uptake?
Selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine and escitalopram inhibit serotonin uptake.
Why is serotonin uptake important in depression?
Inhibiting serotonin uptake increases extracellular serotonin, which is the basis for antidepressant action.
Does serotonin uptake occur outside the brain?
Yes, serotonin uptake occurs in peripheral tissues such as the intestine, where multiple transporters contribute.
Can serotonin uptake be regulated by receptors?
Yes, kappa opioid receptor activation reduces serotonin uptake in the substantia nigra pars reticulata.
What natural compounds affect serotonin uptake?
Licorice constituents have been shown to inhibit serotonin re-uptake.
How does hypoxia affect serotonin uptake?
Mild hypoxia exposure impacts peripheral serotonin uptake and degradation in fish models.
What model systems are used to study serotonin uptake?
Common models include knockout mice, cell lines, and in vitro uptake assays.
Conclusion
GO:0051610 serotonin uptake is a critical biological process that controls serotonin signaling in the brain and periphery. Its dysregulation is linked to depression and gastrointestinal disorders, and it is the target of widely used antidepressants. Continued research using CRISPR models and advanced methods will further elucidate its mechanisms and therapeutic potential.
References
- 1. Fuller RW et al.. 1990. Serotonin uptake and serotonin uptake inhibition.. Ann N Y Acad Sci 600:68-78; discussion 79-80 PMID: 2252338
- 2. Fuller RW. 1994. Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis.. Life Sci 55(3):163-7 PMID: 8007758
- 3. Asberg M et al.. 1986. Therapeutic effects of serotonin uptake inhibitors in depression.. J Clin Psychiatry 47 Suppl:23-35 PMID: 2937776
- 4. Fuller RW et al.. 1991. Fluoxetine, a selective inhibitor of serotonin uptake.. Med Res Rev 11(1):17-34 PMID: 1994152
- 5. Asaji S et al.. 2024. Contributions of multiple transport mechanisms to intestinal uptake of serotonin.. J Pharm Sci 113(11):3216-3226 PMID: 39278593
- 6. West AM et al.. 2023. Kappa Opioid Receptors Reduce Serotonin Uptake and Escitalopram Efficacy in the Mouse Substantia Nigra Pars Reticulata.. Int J Mol Sci 24(3) PMID: 36768403
- 7. Ofir R et al.. 2003. Inhibition of serotonin re-uptake by licorice constituents.. J Mol Neurosci 20(2):135-40 PMID: 12794307
- 8. Sebastiani J et al.. 2022. Mild hypoxia exposure impacts peripheral serotonin uptake and degradation in Gulf toadfish (Opsanus beta).. J Exp Biol 225(13) PMID: 35662341
